Cargando…
Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance
BACKGROUND: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP‐1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcomes, mean there may be benefits to switchi...
Autores principales: | Jain, Akshay B., Ali, Amar, Gorgojo Martínez, Juan J., Hramiak, Irene, Kavia, Ketan, Madsbad, Sten, Potier, Louis, Prohaska, Ben D., Strong, Jodi L., Vilsbøll, Tina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900946/ https://www.ncbi.nlm.nih.gov/pubmed/32975890 http://dx.doi.org/10.1111/ijcp.13731 |
Ejemplares similares
-
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
por: Gorgojo-Martínez, Juan J., et al.
Publicado: (2022) -
Incretin-Based Therapies: Viewpoints on the way to consensus
por: Nauck, Michael. A., et al.
Publicado: (2009) -
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018) -
Functional Abdominal Cramping Pain: Expert Practical Guidance
por: Müller-Lissner, Stefan, et al.
Publicado: (2022) -
Chinese expert consensus statement on metformin in clinical practice
Publicado: (2020)